✉  info@marketresearchfuture.com   📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Carotid Artery Disease Market Research Report Information by Diagnosis & Treatment (Carotid Artery Disease and Antihypertensive Drugs), End User (Hospital & Clinics, Ambulatory Surgical Centers and Pharmacies) and Region (Americas, Europe, Asia-Pacific and the Middle East & Africa) - Forecast till 2030


ID: MRFR/MED/4840-CR | 157 Pages | Author: Kinjoll Dey| July 2019
Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Please fill in Business Email for Quick Response

1 Executive Summary

2 Market Introduction

2.1 Scope of Study 16

2.2 Research Objective 16

2.3 List of Assumptions 17

3 Research process

3.1 Research Process 18

3.2 Primary Research 19

3.3 Secondary Research 20

3.4 Market Size Estimation 21

4 Market Dynamics

4.1 Introduction 22

4.2 Drivers 22

4.2.1 Increasing Geriatric Population 22

4.2.2 Increasing Adoption of Unhealthy Lifestyle 23

4.2.3 Popularity of Over-the-Counter (OTC) Drugs 23

4.3 Restraints 23

4.4 High Cost of Diagnostics and Surgeries 23

4.5 Stringent Government Regulations 23

4.6 Opportunities 24

4.7 Entering Untapped Markets 24

5 Market Factor Analysis

5.1 Value Chain Analysis 25

5.1.1 R&D and Product Development 25

5.1.2 Manufacturing 25

5.1.3 Distribution & Sales 26

5.1.4 Post-Sales Monitoring 26

5.2 Porter’s Five Forces Analysis 27

5.2.1 Bargaining Power of Suppliers 27

5.2.2 Bargaining Power of Buyers 28

5.2.3 Threat of New Entrants 28

5.2.4 Threat of Substitutes 28

5.2.5 Intensity of Rivalry 28

5.3 Investment Opportunity Analysis 29

6 Global Carotid Artery Disease Market by Treatment & Diagnosis

6.1 Introduction 30

6.2 Treatment 33

6.3 Diagnosis 34

7 Global Carotid Artery Disease Market by End User

7.1 Introduction 35

7.2 Hospital & Clinics 36

7.3 Ambulatory Surgical Centers 37

7.4 Pharmacies 37

8 Global Carotid Artery Disease Market by Region

8.1 Introduction 38

8.2 Americas 39

8.2.1 North America 43

8.2.1.1 US 46

8.2.1.2 Canada 49

8.2.2 South America 51

8.3 Europe 54

8.3.1 Western Europe 57

8.3.1.1 Germany 60

8.3.1.2 UK 62

8.3.1.3 France 65

8.3.1.4 Italy 67

8.3.1.5 Spain 70

8.3.1.6 Rest of Western Europe 72

8.3.2 Eastern Europe 75

8.4 Asia-Pacific 78

8.4.1 Japan 81

8.4.2 China 83

8.4.3 India 86

8.4.4 Australia 88

8.4.5 South Korea 91

8.4.6 Rest of Asia-Pacific 93

8.5 Middle East & Africa 96

8.5.1 Middle East 99

8.5.2 Africa 102

9 Competitive Landscape

9.1 Introduction 105

9.2 Key developments 106

10 Company Profiles

10.1 W. L. Gore & Associates, Inc. 109

10.1.1 Company Overview 109

10.1.2 Financial Overview 109

10.1.3 Products/Services Offered 109

10.1.4 Key Developments 109

10.1.5 SWOT Analysis 110

10.1.6 Key Strategies 110

10.2 Becton, Dickinson and Company 111

10.2.1 Company Overview 111

10.2.2 Financial Overview 111

10.2.3 Products/Services Offered 111

10.2.4 Key Developments 112

10.2.5 SWOT Analysis 112

10.2.6 Key Strategies 112

10.3 Terumo Corporation 113

10.3.1 Company Overview 113

10.3.2 Financial Overview 113

10.3.3 Products/Services Offered 113

10.3.4 Key Developments 114

10.3.5 SWOT Analysis 114

10.3.6 Key Strategies 114

10.4 Hitachi, Ltd 115

10.4.1 Company Overview 115

10.4.2 Financial Overview 115

10.4.3 Products/Services Offered 116

10.4.4 Key Developments 116

10.4.5 SWOT Analysis 116

10.4.6 Key Strategies 117

10.5 Silk Road Medical, Inc. 118

10.5.1 Company Overview 118

10.5.2 Financial Overview 118

10.5.3 Products/Services Offered 118

10.5.4 Key Developments 118

10.5.5 SWOT Analysis 119

10.5.6 Key Strategies 119

10.6 Abbott 120

10.6.1 Company Overview 120

10.6.2 Financial Overview 120

10.6.3 Products/Services Offered 121

10.6.4 Key Developments 121

10.6.5 SWOT Analysis 121

10.6.6 Key Strategies 121

10.7 Medtronic 122

10.7.1 Company Overview 122

10.7.2 Financial Overview 122

10.7.3 Products/Services Offered 123

10.7.4 Key Developments 123

10.7.5 SWOT Analysis 123

10.7.6 Key Strategies 123

10.8 Stryker Corporation 124

10.8.1 Company Overview 124

10.8.2 Financial Overview 124

10.8.3 Products/Services Offered 125

10.8.4 Key Developments 125

10.8.5 SWOT Analysis 125

10.8.6 Key Strategies 125

10.9 Cardinal Health 126

10.9.1 Company Overview 126

10.9.2 Financial Overview 126

10.9.3 Products/Services Offered 127

10.9.4 Key Developments 127

10.9.5 SWOT Analysis 127

10.9.6 Key Strategies 127

10.10 Boston Scientific Corporation 128

10.10.1 Company Overview 128

10.10.2 Financial Overview 128

10.10.3 Products/Services Offered 129

10.10.4 Key Developments 129

10.10.5 SWOT Analysis 129

10.10.6 Key Strategies 129

11 Appendix

11.1 References 130

11.2 Related Reports 130

12 List of Tables

TABLE 1 LIST OF ASSUMPTIONS 16

TABLE 2 PRIMARY INTERVIEWS 18

TABLE 3 GLOBAL CAROTID ARTERY DISEASE MARKET, BY TREATMENT & DIAGNOSIS, 2020 TO 2027 (USD MILLION) 30

TABLE 4 GLOBAL CAROTID ARTERY DISEASE MARKET, BY TREATMENT, 2020 TO 2027 (USD MILLION) 31

TABLE 5 GLOBAL CAROTID ARTERY DISEASE MARKET, BY MEDICATION, 2020 TO 2027 (USD MILLION) 31

TABLE 6 GLOBAL CAROTID ARTERY DISEASE MARKET, BY SURGICAL PROCEDURE, 2020 TO 2027 (USD MILLION) 32

TABLE 7 GLOBAL CAROTID ARTERY DISEASE MARKET, FOR TREATMENT, BY REGION, 2020 TO 2027 (USD MILLION) 32

TABLE 8 GLOBAL CAROTID ARTERY DISEASE MARKET, FOR DIAGNOSIS, BY REGION, 2020 TO 2027 (USD MILLION) 33

TABLE 9 GLOBAL CAROTID ARTERY DISEASE MARKET, BY END USER, 2020 TO 2027 (USD MILLION) 34

TABLE 10 GLOBAL CAROTID ARTERY DISEASE MARKET, FOR HOSPITAL & CLINICS, BY REGION, 2020 TO 2027 (USD MILLION) 35

TABLE 11 GLOBAL CAROTID ARTERY DISEASE MARKET, FOR AMBULATORY SURGICAL CENTERS, BY REGION,

2020 TO 2027 (USD MILLION) 36

TABLE 12 GLOBAL CAROTID ARTERY DISEASE MARKET, FOR PHARMACIES, BY REGION, 2020 TO 2027 (USD MILLION) 36

TABLE 13 GLOBAL CAROTID ARTERY DISEASE MARKET, BY REGION, 2020 TO 2027 (USD MILLION) 37

TABLE 14 AMERICAS: CAROTID ARTERY DISEASE MARKET, BY REGION, 2020 TO 2027 (USD MILLION) 38

TABLE 15 AMERICAS: CAROTID ARTERY DISEASE MARKET, BY SURGERY, 2020 TO 2027 (PROCEDURES) 39

TABLE 16 AMERICAS: CAROTID ARTERY DISEASE MARKET, BY TREATMENT & DIAGNOSIS, 2020 TO 2027 (USD MILLION) 39

TABLE 17 AMERICAS: CAROTID ARTERY DISEASE MARKET, BY TREATMENT, 2020 TO 2027 (USD MILLION) 39

TABLE 18 AMERICAS: CAROTID ARTERY DISEASE MARKET, BY MEDICATION, 2020 TO 2027 (USD MILLION) 40

TABLE 19 AMERICAS: CAROTID ARTERY DISEASE MARKET, BY SURGICAL PROCEDURE, 2020 TO 2027 (USD MILLION) 40

TABLE 20 AMERICAS: CAROTID ARTERY DISEASE MARKET, BY END USER, 2020 TO 2027 (USD MILLION) 41

TABLE 21 NORTH AMERICA: CAROTID ARTERY DISEASE MARKET, BY REGION, 2020 TO 2027 (USD MILLION) 41

TABLE 22 NORTH AMERICA: CAROTID ARTERY DISEASE MARKET, BY TREATMENT & DIAGNOSIS, 2020 TO 2027 (USD MILLION) 42

TABLE 23 NORTH AMERICA: CAROTID ARTERY DISEASE MARKET, BY TREATMENT, 2020 TO 2027 (USD MILLION) 42

TABLE 24 NORTH AMERICA: CAROTID ARTERY DISEASE MARKET, BY MEDICATION, 2020 TO 2027 (USD MILLION) 43

TABLE 25 NORTH AMERICA: CAROTID ARTERY DISEASE MARKET, BY SURGICAL PROCEDURE, 2020 TO 2027 (USD MILLION) 43

TABLE 26 NORTH AMERICA: CAROTID ARTERY DISEASE MARKET, BY END USER, 2020 TO 2027 (USD MILLION) 44

TABLE 27 US: CAROTID ARTERY DISEASE MARKET, BY TREATMENT & DIAGNOSIS, 2020 TO 2027 (USD MILLION) 44

TABLE 28 US: CAROTID ARTERY DISEASE MARKET, BY TREATMENT, 2020 TO 2027 (USD MILLION) 45

TABLE 29 US: CAROTID ARTERY DISEASE MARKET, BY MEDICATION, 2020 TO 2027 (USD MILLION) 45

TABLE 30 US: CAROTID ARTERY DISEASE MARKET, BY SURGICAL PROCEDURE, 2020 TO 2027 (USD MILLION) 46

TABLE 31 US: CAROTID ARTERY DISEASE MARKET, BY END USER, 2020 TO 2027 (USD MILLION) 46

TABLE 32 CANADA: CAROTID ARTERY DISEASE MARKET, BY TREATMENT & DIAGNOSIS, 2020 TO 2027 (USD MILLION) 47

TABLE 33 CANADA: CAROTID ARTERY DISEASE MARKET, BY TREATMENT, 2020 TO 2027 (USD MILLION) 47

TABLE 34 CANADA: CAROTID ARTERY DISEASE MARKET, BY MEDICATION, 2020 TO 2027 (USD MILLION) 48

TABLE 35 CANADA: CAROTID ARTERY DISEASE MARKET, BY SURGICAL PROCEDURE, 2020 TO 2027 (USD MILLION) 48

TABLE 36 CANADA: CAROTID ARTERY DISEASE MARKET, BY END USER, 2020 TO 2027 (USD MILLION) 49

TABLE 37 SOUTH AMERICA: CAROTID ARTERY DISEASE MARKET, BY TREATMENT & DIAGNOSIS, 2020 TO 2027 (USD MILLION) 49

TABLE 38 SOUTH AMERICA: CAROTID ARTERY DISEASE MARKET, BY TREATMENT, 2020 TO 2027 (USD MILLION) 50

TABLE 39 SOUTH AMERICA: CAROTID ARTERY DISEASE MARKET, BY MEDICATION, 2020 TO 2027 (USD MILLION) 50

TABLE 40 SOUTH AMERICA: CAROTID ARTERY DISEASE MARKET, BY SURGICAL PROCEDURE, 2020 TO 2027 (USD MILLION) 51

TABLE 41 SOUTH AMERICA: CAROTID ARTERY DISEASE MARKET, BY END USER, 2020 TO 2027 (USD MILLION) 51

TABLE 42 EUROPE: CAROTID ARTERY DISEASE MARKET, BY REGION, 2020 TO 2027 (USD MILLION) 52

TABLE 43 EUROPE: CAROTID ARTERY DISEASE MARKET, BY SURGERY, 2020 TO 2027 (PROCEDURES) 52

TABLE 44 EUROPE: CAROTID ARTERY DISEASE MARKET, BY TREATMENT & DIAGNOSIS, 2020 TO 2027 (USD MILLION) 53

TABLE 45 EUROPE: CAROTID ARTERY DISEASE MARKET, BY TREATMENT, 2020 TO 2027 (USD MILLION) 53

TABLE 46 EUROPE: CAROTID ARTERY DISEASE MARKET, BY MEDICATION, 2020 TO 2027 (USD MILLION) 53

TABLE 47 EUROPE: CAROTID ARTERY DISEASE MARKET, BY SURGICAL PROCEDURE, 2020 TO 2027 (USD MILLION) 54

TABLE 48 EUROPE: CAROTID ARTERY DISEASE MARKET, BY END USER, 2020 TO 2027 (USD MILLION) 54

TABLE 49 WESTERN EUROPE: CAROTID ARTERY DISEASE MARKET, BY REGION, 2020 TO 2027 (USD MILLION) 55

TABLE 50 WESTERN EUROPE: CAROTID ARTERY DISEASE MARKET, BY TREATMENT & DIAGNOSIS, 2020 TO 2027 (USD MILLION) 56

TABLE 51 WESTERN EUROPE: CAROTID ARTERY DISEASE MARKET, BY TREATMENT, 2020 TO 2027 (USD MILLION) 56

TABLE 52 WESTERN EUROPE: CAROTID ARTERY DISEASE MARKET, BY MEDICATION, 2020 TO 2027 (USD MILLION) 56

TABLE 53 WESTERN EUROPE: CAROTID ARTERY DISEASE MARKET, BY SURGICAL PROCEDURE, 2020 TO 2027 (USD MILLION) 57

TABLE 54 WESTERN EUROPE: CAROTID ARTERY DISEASE MARKET, BY END USER, 2020 TO 2027 (USD MILLION) 57

TABLE 55 GERMANY: CAROTID ARTERY DISEASE MARKET, BY TREATMENT & DIAGNOSIS, 2020 TO 2027 (USD MILLION) 58

TABLE 56 GERMANY: CAROTID ARTERY DISEASE MARKET, BY TREATMENT, 2020 TO 2027 (USD MILLION) 58

TABLE 57 GERMANY: CAROTID ARTERY DISEASE MARKET, BY MEDICATION, 2020 TO 2027 (USD MILLION) 59

TABLE 58 GERMANY: CAROTID ARTERY DISEASE MARKET, BY SURGICAL PROCEDURE, 2020 TO 2027 (USD MILLION) 59

TABLE 59 GERMANY: CAROTID ARTERY DISEASE MARKET, BY END USER, 2020 TO 2027 (USD MILLION) 60

TABLE 60 UK: CAROTID ARTERY DISEASE MARKET, BY TREATMENT & DIAGNOSIS, 2020 TO 2027 (USD MILLION) 60

TABLE 61 UK: CAROTID ARTERY DISEASE MARKET, BY TREATMENT, 2020 TO 2027 (USD MILLION) 61

TABLE 62 UK: CAROTID ARTERY DISEASE MARKET, BY MEDICATION, 2020 TO 2027 (USD MILLION) 61

TABLE 63 UK: CAROTID ARTERY DISEASE MARKET, BY SURGICAL PROCEDURE, 2020 TO 2027 (USD MILLION) 62

TABLE 64 UK: CAROTID ARTERY DISEASE MARKET, BY END USER, 2020 TO 2027 (USD MILLION) 62

TABLE 65 FRANCE: CAROTID ARTERY DISEASE MARKET, BY TREATMENT & DIAGNOSIS, 2020 TO 2027 (USD MILLION) 63

TABLE 66 FRANCE: CAROTID ARTERY DISEASE MARKET, BY TREATMENT, 2020 TO 2027 (USD MILLION) 63

TABLE 67 FRANCE: CAROTID ARTERY DISEASE MARKET, BY MEDICATION, 2020 TO 2027 (USD MILLION) 64

TABLE 68 FRANCE: CAROTID ARTERY DISEASE MARKET, BY SURGICAL PROCEDURE, 2020 TO 2027 (USD MILLION) 64

TABLE 69 FRANCE: CAROTID ARTERY DISEASE MARKET, BY END USER, 2020 TO 2027 (USD MILLION) 65

TABLE 70 ITALY: CAROTID ARTERY DISEASE MARKET, BY TREATMENT & DIAGNOSIS, 2020 TO 2027 (USD MILLION) 65

TABLE 71 ITALY: CAROTID ARTERY DISEASE MARKET, BY TREATMENT, 2020 TO 2027 (USD MILLION) 66

TABLE 72 ITALY: CAROTID ARTERY DISEASE MARKET, BY MEDICATION, 2020 TO 2027 (USD MILLION) 66

TABLE 73 ITALY: CAROTID ARTERY DISEASE MARKET, BY SURGICAL PROCEDURE, 2020 TO 2027 (USD MILLION) 67

TABLE 74 ITALY: CAROTID ARTERY DISEASE MARKET, BY END USER, 2020 TO 2027 (USD MILLION) 67

TABLE 75 SPAIN: CAROTID ARTERY DISEASE MARKET, BY TREATMENT & DIAGNOSIS, 2020 TO 2027 (USD MILLION) 68

TABLE 76 SPAIN: CAROTID ARTERY DISEASE MARKET, BY TREATMENT, 2020 TO 2027 (USD MILLION) 68

TABLE 77 SPAIN: CAROTID ARTERY DISEASE MARKET, BY MEDICATION, 2020 TO 2027 (USD MILLION) 69

TABLE 78 SPAIN: CAROTID ARTERY DISEASE MARKET, BY SURGICAL PROCEDURE, 2020 TO 2027 (USD MILLION) 69

TABLE 79 SPAIN: CAROTID ARTERY DISEASE MARKET, BY END USER, 2020 TO 2027 (USD MILLION) 70

TABLE 80 REST OF WESTERN EUROPE: CAROTID ARTERY DISEASE MARKET, BY TREATMENT & DIAGNOSIS,

2020 TO 2027 (USD MILLION) 70

TABLE 81 REST OF WESTERN EUROPE: CAROTID ARTERY DISEASE MARKET, BY TREATMENT, 2020 TO 2027 (USD MILLION) 71

TABLE 82 REST OF WESTERN EUROPE: CAROTID ARTERY DISEASE MARKET, BY MEDICATION, 2020 TO 2027 (USD MILLION) 71

TABLE 83 REST OF WESTERN EUROPE: CAROTID ARTERY DISEASE MARKET, BY SURGICAL PROCEDURE, 2020 TO 2027 (USD MILLION) 72

TABLE 84 REST OF WESTERN EUROPE: CAROTID ARTERY DISEASE MARKET, BY END USER, 2020 TO 2027 (USD MILLION) 72

TABLE 85 EASTERN EUROPE: CAROTID ARTERY DISEASE MARKET, BY TREATMENT & DIAGNOSIS, 2020 TO 2027 (USD MILLION) 73

TABLE 86 EASTERN EUROPE: CAROTID ARTERY DISEASE MARKET, BY TREATMENT, 2020 TO 2027 (USD MILLION) 73

TABLE 87 EASTERN EUROPE: CAROTID ARTERY DISEASE MARKET, BY MEDICATION, 2020 TO 2027 (USD MILLION) 74

TABLE 88 EASTERN EUROPE: CAROTID ARTERY DISEASE MARKET, BY SURGICAL PROCEDURE, 2020 TO 2027 (USD MILLION) 74

TABLE 89 EASTERN EUROPE: CAROTID ARTERY DISEASE MARKET, BY END USER, 2020 TO 2027 (USD MILLION) 75

TABLE 90 ASIA-PACIFIC: CAROTID ARTERY DISEASE MARKET, BY REGION, 2020 TO 2027 (USD MILLION) 76

TABLE 91 ASIA-PACIFIC: CAROTID ARTERY DISEASE MARKET, BY SURGERY, 2020 TO 2027 (PROCEDURES) 76

TABLE 92 ASIA-PACIFIC: CAROTID ARTERY DISEASE MARKET, BY TREATMENT & DIAGNOSIS, 2020 TO 2027 (USD MILLION) 76

TABLE 93 ASIA-PACIFIC: CAROTID ARTERY DISEASE MARKET, BY TREATMENT, 2020 TO 2027 (USD MILLION) 77

TABLE 94 ASIA-PACIFIC: CAROTID ARTERY DISEASE MARKET, BY MEDICATION, 2020 TO 2027 (USD MILLION) 77

TABLE 95 ASIA-PACIFIC: CAROTID ARTERY DISEASE MARKET, BY SURGICAL PROCEDURE, 2020 TO 2027 (USD MILLION) 77

TABLE 96 ASIA-PACIFIC: CAROTID ARTERY DISEASE MARKET, BY END USER, 2020 TO 2027 (USD MILLION) 78

TABLE 97 JAPAN: CAROTID ARTERY DISEASE MARKET, BY TREATMENT & DIAGNOSIS, 2020 TO 2027 (USD MILLION) 79

TABLE 98 JAPAN: CAROTID ARTERY DISEASE MARKET, BY TREATMENT, 2020 TO 2027 (USD MILLION) 79

TABLE 99 JAPAN: CAROTID ARTERY DISEASE MARKET, BY MEDICATION, 2020 TO 2027 (USD MILLION) 80

TABLE 100 JAPAN: CAROTID ARTERY DISEASE MARKET, BY SURGICAL PROCEDURE, 2020 TO 2027 (USD MILLION) 80

TABLE 101 JAPAN: CAROTID ARTERY DISEASE MARKET, BY END USER, 2020 TO 2027 (USD MILLION) 81

TABLE 102 CHINA: CAROTID ARTERY DISEASE MARKET, BY TREATMENT & DIAGNOSIS, 2020 TO 2027 (USD MILLION) 81

TABLE 103 CHINA: CAROTID ARTERY DISEASE MARKET, BY TREATMENT, 2020 TO 2027 (USD MILLION) 82

TABLE 104 CHINA: CAROTID ARTERY DISEASE MARKET, BY MEDICATION, 2020 TO 2027 (USD MILLION) 82

TABLE 105 CHINA: CAROTID ARTERY DISEASE MARKET, BY SURGICAL PROCEDURE, 2020 TO 2027 (USD MILLION) 83

TABLE 106 CHINA: CAROTID ARTERY DISEASE MARKET, BY END USER, 2020 TO 2027 (USD MILLION) 83

TABLE 107 INDIA: CAROTID ARTERY DISEASE MARKET, BY TREATMENT & DIAGNOSIS, 2020 TO 2027 (USD MILLION) 84

TABLE 108 INDIA: CAROTID ARTERY DISEASE MARKET, BY TREATMENT, 2020 TO 2027 (USD MILLION) 84

TABLE 109 INDIA: CAROTID ARTERY DISEASE MARKET, BY MEDICATION, 2020 TO 2027 (USD MILLION) 85

TABLE 110 INDIA: CAROTID ARTERY DISEASE MARKET, BY SURGICAL PROCEDURE, 2020 TO 2027 (USD MILLION) 85

TABLE 111 INDIA: CAROTID ARTERY DISEASE MARKET, BY END USER, 2020 TO 2027 (USD MILLION) 86

TABLE 112 AUSTRALIA: CAROTID ARTERY DISEASE MARKET, BY TREATMENT & DIAGNOSIS, 2020 TO 2027 (USD MILLION) 86

TABLE 113 AUSTRALIA: CAROTID ARTERY DISEASE MARKET, BY TREATMENT, 2020 TO 2027 (USD MILLION) 87

TABLE 114 AUSTRALIA: CAROTID ARTERY DISEASE MARKET, BY MEDICATION, 2020 TO 2027 (USD MILLION) 87

TABLE 115 AUSTRALIA: CAROTID ARTERY DISEASE MARKET, BY SURGICAL PROCEDURE, 2020 TO 2027 (USD MILLION) 88

TABLE 116 AUSTRALIA: CAROTID ARTERY DISEASE MARKET, BY END USER, 2020 TO 2027 (USD MILLION) 88

TABLE 117 SOUTH KOREA: CAROTID ARTERY DISEASE MARKET, BY TREATMENT & DIAGNOSIS, 2020 TO 2027 (USD MILLION) 89

TABLE 118 SOUTH KOREA: CAROTID ARTERY DISEASE MARKET, BY TREATMENT, 2020 TO 2027 (USD MILLION) 89

TABLE 119 SOUTH KOREA: CAROTID ARTERY DISEASE MARKET, BY MEDICATION, 2020 TO 2027 (USD MILLION) 90

TABLE 120 SOUTH KOREA: CAROTID ARTERY DISEASE MARKET, BY SURGICAL PROCEDURE, 2020 TO 2027 (USD MILLION) 90

TABLE 121 SOUTH KOREA: CAROTID ARTERY DISEASE MARKET, BY END USER, 2020 TO 2027 (USD MILLION) 91

TABLE 122 REST OF ASIA-PACIFIC: CAROTID ARTERY DISEASE MARKET, BY TREATMENT & DIAGNOSIS, 2020 TO 2027 (USD MILLION) 91

TABLE 123 REST OF ASIA-PACIFIC: CAROTID ARTERY DISEASE MARKET, BY TREATMENT, 2020 TO 2027 (USD MILLION) 92

TABLE 124 REST OF ASIA-PACIFIC: CAROTID ARTERY DISEASE MARKET, BY MEDICATION, 2020 TO 2027 (USD MILLION) 92

TABLE 125 REST OF ASIA-PACIFIC: CAROTID ARTERY DISEASE MARKET, BY SURGICAL PROCEDURE, 2020 TO 2027 (USD MILLION) 93

TABLE 126 REST OF ASIA-PACIFIC: CAROTID ARTERY DISEASE MARKET, BY END USER, 2020 TO 2027 (USD MILLION) 93

TABLE 127 MIDDLE EAST & AFRICA: CAROTID ARTERY DISEASE MARKET, BY REGION, 2020 TO 2027 (USD MILLION) 94

TABLE 128 MIDDLE EAST & AFRICA: CAROTID ARTERY DISEASE MARKET, BY SURGERY, 2020 TO 2027 (PROCEDURE) 94

TABLE 129 MIDDLE EAST & AFRICA: CAROTID ARTERY DISEASE MARKET, BY TREATMENT & DIAGNOSIS, 2020 TO 2027 (USD MILLION) 95

TABLE 130 MIDDLE EAST & AFRICA: CAROTID ARTERY DISEASE MARKET, BY TREATMENT, 2020 TO 2027 (USD MILLION) 95

TABLE 131 MIDDLE EAST & AFRICA: CAROTID ARTERY DISEASE MARKET, BY MEDICATION, 2020 TO 2027 (USD MILLION) 96

TABLE 132 MIDDLE EAST & AFRICA: CAROTID ARTERY DISEASE MARKET, BY SURGICAL PROCEDURE, 2020 TO 2027 (USD MILLION) 96

TABLE 133 MIDDLE EAST & AFRICA: CAROTID ARTERY DISEASE MARKET, BY END USER, 2020 TO 2027 (USD MILLION) 97

TABLE 134 MIDDLE EAST: CAROTID ARTERY DISEASE MARKET, BY TREATMENT & DIAGNOSIS, 2020 TO 2027 (USD MILLION) 97

TABLE 135 MIDDLE EAST: CAROTID ARTERY DISEASE MARKET, BY TREATMENT, 2020 TO 2027 (USD MILLION) 98

TABLE 136 MIDDLE EAST: CAROTID ARTERY DISEASE MARKET, BY MEDICATION, 2020 TO 2027 (USD MILLION) 98

TABLE 137 MIDDLE EAST: CAROTID ARTERY DISEASE MARKET, BY SURGICAL PROCEDURE, 2020 TO 2027 (USD MILLION) 99

TABLE 138 MIDDLE EAST: CAROTID ARTERY DISEASE MARKET, BY END USER, 2020 TO 2027 (USD MILLION) 99

TABLE 139 AFRICA: CAROTID ARTERY DISEASE MARKET, BY TREATMENT & DIAGNOSIS, 2020 TO 2027 (USD MILLION) 100

TABLE 140 AFRICA: CAROTID ARTERY DISEASE MARKET, BY TREATMENT, 2020 TO 2027 (USD MILLION) 100

TABLE 141 AFRICA: CAROTID ARTERY DISEASE MARKET, BY MEDICATION, 2020 TO 2027 (USD MILLION) 101

TABLE 142 AFRICA: CAROTID ARTERY DISEASE MARKET, BY SURGICAL PROCEDURE, 2020 TO 2027 (USD MILLION) 101

TABLE 143 AFRICA: CAROTID ARTERY DISEASE MARKET, BY END USER, 2020 TO 2027 (USD MILLION) 102

TABLE 144 MAJOR MANUFACTURERS IN THE GLOBAL CAROTID ARTERY DISEASE MARKET 103

TABLE 145 KEY DEVELOPMENTS BY PLAYERS IN THE MARKET 104

13 List of Figures

FIGURE 1 MARKET SYNOPSIS 14

FIGURE 2 GLOBAL CAROTID ARTERY DISEASE MARKET: STRUCTURE 16

FIGURE 3 RESEARCH PROCESS 17

FIGURE 4 TOP-DOWN AND BOTTOM-UP APPROACHES 20

FIGURE 5 MARKET DYNAMICS: ANALYSIS OF THE CAROTID ARTERY DISEASE MARKET 21

FIGURE 6 VALUE CHAIN ANALYSIS: GLOBAL CAROTID ARTERY DISEASE MARKET 24

FIGURE 7 PORTER’S FIVE FORCE ANALYSIS: GLOBAL CAROTID ARTERY DISEASE MARKET 26

FIGURE 8 GLOBAL CAROTID ARTERY DISEASE MARKET, BY TREATMENT & DIAGNOSIS, 2020 & 2027 (USD MILLION) 30

FIGURE 9 GLOBAL CAROTID ARTERY DISEASE MARKET, BY END USER, 2020 & 2027 (USD MILLION) 35

FIGURE 10 GLOBAL CAROTID ARTERY DISEASE MARKET SHARE, BY REGION, 2020 (%) 37

FIGURE 11 AMERICAS: CAROTID ARTERY DISEASE MARKET SHARE, BY REGION, 2020 (%) 38

FIGURE 12 NORTH AMERICA: CAROTID ARTERY DISEASE MARKET SHARE, BY REGION, 2020 (%) 42

FIGURE 13 EUROPE: CAROTID ARTERY DISEASE MARKET SHARE, BY REGION, 2020 (%) 52

FIGURE 14 WESTERN EUROPE: CAROTID ARTERY DISEASE MARKET SHARE, BY REGION, 2020 (%) 55

FIGURE 15 ASIA-PACIFIC: CAROTID ARTERY DISEASE MARKET SHARE, BY REGION, 2020 (%) 76

FIGURE 16 MIDDLE EAST & AFRICA: CAROTID ARTERY DISEASE MARKET SHARE, BY REGION, 2020 (%) 94

FIGURE 17 CATEGORY WISE SHARE OF KEY DEVELOPMENTS 106

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.
Related Reports
report-img
LDL Test Market Research Report- Global Forecast Till 2030
Press Release
pr-img
The Global Carotid Artery Disease Market Is Expected To Grow At CAGR Of 4.1% the Forecast Period ...
Logo
Dmca Cloudflare ssl
Paypal footer Ssl
Services Industry Expertise Consulting Services Articles How To Order FAQs
Our Company About US Careers Contact Us Terms & Conditions Privacy Policy
Banking Partners
Amex Mastercard1
Razerpay
Hdfcbank
Visa
✉  info@marketresearchfuture.com
📞  +1 (855) 661-4441(US)
📞  +44 1720 412 167(UK)

© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)